Medication info

New Gliasyrup (Choline Alphoscerate)

Prescription medicationSyrupOral
Ingredient · strength
Choline Alfoscerate›400mg / 1 packet
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
This medicine is a colorless or pale yellow syrup with a flavorful sweetness, contained in an aluminum foil pouch.
Packaging
30 pouches/pack [8mL/pouch X 30]
Approval status
Active

MFDS item code 201906062 · Notified 2019.08.26

Summary

Main use
Improvement of cerebrovascular deficits and degenerative organic brain symptoms (e.g., memory impairment and confusion)
Who takes it
Adults
Adult dose
Administer 400 mg (1 sachet) of choline alfoscerate orally 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of cerebrovascular deficits and degenerative organic brain symptoms (e.g., memory impairment and confusion)

  • memory impairment
  • confusion
  • disorientation
  • decreased motivation
  • decreased spontaneity
  • reduced concentration
View approved original text

This medication is used for secondary symptoms resulting from cerebrovascular deficits, and for degenerative or progressive organic psychiatric syndrome. It particularly helps to improve symptoms such as memory impairment, confusion, disorientation, decreased motivation and spontaneity, and reduced concentration. Clinical trial results in South Korea have also confirmed these effects, contributing to the alleviation of patients' symptoms. Therefore, it can be effectively used for these neurological issues.

How to take

Adult dose

Administer 400 mg (1 sachet) of choline alfoscerate orally 2~3 times daily. Adjust the dose as appropriate according to symptoms.

Precautions

This medication should not be used in patients who are allergic to this drug or any of its ingredients. It is also advisable for women who are pregnant or may become pregnant to avoid taking this medication. Nausea may occur during treatment, which is due to the medication’s effect on dopamine. If such symptoms appear, the dosage should be reduced. Care should be taken as it may affect the digestive system, possibly leading to gastritis or other stomach-related diseases. It may also affect the central nervous system, leading to symptoms such as drowsiness, insomnia, irritability, nervousness, convulsions, or excessive movement. This medicine should be kept out of the reach of children. Additionally, transferring this medication to another container should be avoided as it may increase the risk of accidents and deteriorate the quality of the drug.

Side effects

  • Area
  • gastritis
  • gastric disorders
  • drowsiness
  • insomnia
  • aggression
  • irritability
  • convulsions
  • hyperactivity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air or moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

This medicine is a colorless or pale yellow syrup with a flavorful sweetness, contained in an aluminum foil pouch.

Package unit

30 pouches/pack [8mL/pouch X 30]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.